Tandem Diabetes Care (TNDM) Tax Rate Growth (1y) (2019 - 2026)
Tandem Diabetes Care (TNDM) Tax Rate Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.75 Bn | 176.46 Bn | 6.27 Bn |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.61 Bn | 67.16 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.41 Bn | 44.74 Bn | 1.29 Bn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.12 Bn | 25.83 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 24.26 Bn | 21.14 Bn | 2.07 Bn |
| 10 | Tandem Diabetes Care | 1.14 Bn | 567.87 Mn | 136.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 445.00 |
| Dec 31, 2025 | 473,023.00 |
| Sep 30, 2025 | 1,847.00 |
| Jun 30, 2025 | 1,278.00 |
| Mar 31, 2025 | 113.00 |
| Dec 31, 2024 | -462,304.00 |
| Sep 30, 2024 | 461.00 |
| Jun 30, 2024 | -29.00 |
| Mar 31, 2024 | -785.00 |
| Dec 31, 2023 | 267.00 |
| Sep 30, 2023 | -388.00 |
| Jun 30, 2023 | 1,290.00 |
| Mar 31, 2023 | -1,058.00 |
| Dec 31, 2022 | -142.00 |
| Sep 30, 2022 | -431.00 |
| Jun 30, 2022 | -1,866.00 |
| Mar 31, 2022 | 842.00 |
| Sep 30, 2021 | 135.00 |
| Jun 30, 2021 | 248.00 |
| Mar 31, 2021 | 259.00 |